ARL5C: A Potential Drug Target for Various Diseases (G390790)

Target Name: ARL5C

NCBI ID: G390790

ARL5C

ARL5C: A Potential Drug Target for Various Diseases

ARL5C (ARL12) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the T-cell antigen receptor family 5 (TARF5) and is involved in the regulation of cell signaling pathways. ARL5C has been identified as a potential drug target for the treatment of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The discovery of ARL5C as a potential drug target stems from its involvement in several cellular processes that are important for disease development and progression. One of the key functions of ARL5C is its role in the regulation of T cell responses to antigens. ARL5C is a critical It is a critical regulator of the adapter transducer complex (STTAC), which is a protein that activates the MAPK/ERK signaling pathway. This signaling pathway is involved in the regulation of cell proliferation, differentiation, and survival.

ARL5C is also involved in the regulation of inflammation and immune responses. It has been shown to play a role in the regulation of T cell responses to bacteria and viruses, as well as in the regulation of inflammation in the body. This protein has been shown to be involved in the development of various autoimmune diseases, including rheumatoid arthritis, lupus, and multiple sclerosis.

In addition to its role in T cell signaling and immune responses, ARL5C is also involved in the regulation of cell survival and metabolism. It has been shown to play a role in the regulation of cell cycle progression, cell apoptosis, and cellular metabolism. This Protein has been shown to be involved in the development of various types of cancer, including breast, lung, and ovarian cancer.

The potential drug targets for ARL5C are numerous and range from inhibiting its ability to regulate T cell signaling and immune responses, to blocking its role in the regulation of cell cycle progression and apoptosis. There is also evidence to suggest that ARL5C may be a potential target for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, as it is involved in the regulation of neurodegeneration.

In conclusion, ARL5C is a protein that has the potential to be a drug target for the treatment of a wide range of diseases. Its involvement in T cell signaling and immune responses, as well as its role in the regulation of cell cycle progression, apoptosis , and metabolism, make it an attractive target for drug development. Further research is needed to fully understand the mechanisms of ARL5C's role in disease and to develop effective treatments.

Protein Name: ADP Ribosylation Factor Like GTPase 5C

Functions: Binds and exchanges GTP and GDP

The "ARL5C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ARL5C comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets